铂类化疗成功治疗两例连续性肺多形性癌
Successful treatment of two consecutive cases of pulmonary pleomorphic carcinoma with platinum chemotherapy.
作者信息
Kato Daisuke, Chihara Yuichi, Shirase Tomoyuki, Takahashi Tamaki, Takahashi Ken-Ichi, Sakai Naoki
机构信息
Respiratory Disease Center, Otsu Red Cross Hospital, Otsu, Shiga 520-8511, Japan.
Department of Pathology, Otsu Red Cross Hospital, Otsu, Shiga 520-8511, Japan.
出版信息
Oncol Lett. 2015 Nov;10(5):3040-3042. doi: 10.3892/ol.2015.3678. Epub 2015 Sep 3.
Abstract
Pulmonary pleomorphic carcinoma (PPC) is a rare pulmonary malignant tumor that has a more aggressive clinical course and a poorer prognosis compared with non-small cell lung cancer (NSCLC) due to its resistance to chemotherapy and radiotherapy. In patients with advanced or relapsed PPC, it has been reported that the response rate to chemotherapy regimens known to be effective in patients with NSCLC is only 0-17%. The present study reports the cases of two consecutive patients with advanced PPC who exhibited marked responses to chemotherapy with carboplatin plus paclitaxel chemotherapy and long-term survival without tumor progression. This suggests that carboplatin plus paclitaxel chemotherapy is a good option for the treatment of advanced PPC.
摘要
肺多形性癌（PPC）是一种罕见的肺恶性肿瘤，由于其对化疗和放疗具有抗性，与非小细胞肺癌（NSCLC）相比，具有更具侵袭性的临床病程和更差的预后。据报道，在晚期或复发的PPC患者中，对已知对NSCLC患者有效的化疗方案的缓解率仅为0-17%。本研究报告了两名连续的晚期PPC患者的病例，他们对卡铂加紫杉醇化疗表现出显著反应，并长期生存且无肿瘤进展。这表明卡铂加紫杉醇化疗是治疗晚期PPC的一个良好选择。
相似文献
1
Successful treatment of two consecutive cases of pulmonary pleomorphic carcinoma with platinum chemotherapy.
Oncol Lett. 2015 Nov;10(5):3040-3042. doi: 10.3892/ol.2015.3678. Epub 2015 Sep 3.
2
Promising effect of chemotherapy with bevacizumab for patients with pulmonary pleomorphic carcinoma: Two case reports and a literature review.
Respir Investig. 2015 Nov;53(6):296-9. doi: 10.1016/j.resinv.2015.05.004. Epub 2015 Aug 12.
3
Palliative chemotherapy for pulmonary pleomorphic carcinoma.
Lung Cancer. 2007 Oct;58(1):112-5. doi: 10.1016/j.lungcan.2007.05.006. Epub 2007 Jun 18.
4
Medical therapy of advanced malignant epithelial tumours of the ovary.
Forum (Genova). 2000 Oct-Dec;10(4):323-32.
5
Paclitaxel: a pharmacoeconomic review of its use in non-small cell lung cancer.
Pharmacoeconomics. 2001;19(11):1111-34. doi: 10.2165/00019053-200119110-00005.
6
Pemetrexed and bevacizumab-containing chemotherapy for pleomorphic carcinoma of the lung.
Mol Clin Oncol. 2016 Apr;4(4):616-618. doi: 10.3892/mco.2016.758. Epub 2016 Jan 29.
7
Effective combined therapy with ramucirumab for advanced pulmonary pleomorphic carcinoma.
Respirol Case Rep. 2018 Sep 28;6(8):e00372. doi: 10.1002/rcr2.372. eCollection 2018 Nov.
8
The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma.
Med Oncol. 2009;26(3):287-91. doi: 10.1007/s12032-008-9117-4. Epub 2008 Nov 7.
9
Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy.
Jpn J Clin Oncol. 2011 Mar;41(3):430-3. doi: 10.1093/jjco/hyq180. Epub 2010 Oct 5.
10
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12.
引用本文的文献
1
Treatment strategies for rapid recurrence and progression after surgery for stage I pulmonary pleomorphic carcinoma: a case report and literature review.
Front Immunol. 2025 Jun 4;16:1547872. doi: 10.3389/fimmu.2025.1547872. eCollection 2025.
2
Clinicopathological characteristics, survival outcomes and prognostic factors in pleomorphic carcinoma: a SEER population-based study.
BMC Pulm Med. 2022 Mar 31;22(1):116. doi: 10.1186/s12890-022-01915-1.
3
Robust response of pulmonary pleomorphic carcinoma to pembrolizumab and sequential radiotherapy: A case report.
Respirol Case Rep. 2021 Nov 10;9(12):e0875. doi: 10.1002/rcr2.875. eCollection 2021 Dec.
4
Combination of Pembrolizumab With Platinum-containing Chemotherapy for Pleomorphic Carcinoma of the Lung.
In Vivo. 2020 May-Jun;34(3):1439-1443. doi: 10.21873/invivo.11926.
5
Long-term response with durvalumab after chemoradiotherapy for pulmonary pleomorphic carcinoma: A case report.
Thorac Cancer. 2020 Apr;11(4):1090-1093. doi: 10.1111/1759-7714.13331. Epub 2020 Feb 11.
6
A rare presentation of pleomorphic carcinoma of lung mimic empyema.
Ann Transl Med. 2019 Feb;7(3):52. doi: 10.21037/atm.2018.12.19.
7
Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report.
Case Rep Oncol. 2018 May 31;11(2):336-340. doi: 10.1159/000489392. eCollection 2018 May-Aug.
本文引用的文献
1
Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysis.
Surgery. 2012 Sep;152(3):397-402. doi: 10.1016/j.surg.2012.05.007. Epub 2012 Jun 26.
2
Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung.
Oncology. 2011;81(3-4):206-13. doi: 10.1159/000333095. Epub 2011 Nov 9.
3
Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy.
Jpn J Clin Oncol. 2011 Mar;41(3):430-3. doi: 10.1093/jjco/hyq180. Epub 2010 Oct 5.
4
Clinical characteristics of pleomorphic carcinoma of the lung.
Lung Cancer. 2010 May;68(2):204-10. doi: 10.1016/j.lungcan.2009.06.002. Epub 2009 Jul 3.
5
The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma.
Med Oncol. 2009;26(3):287-91. doi: 10.1007/s12032-008-9117-4. Epub 2008 Nov 7.
6
Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases.
Am J Surg Pathol. 2008 Nov;32(11):1727-35. doi: 10.1097/PAS.0b013e3181804302.
7
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.
J Thorac Oncol. 2007 Aug;2(8):706-14. doi: 10.1097/JTO.0b013e31812f3c1a.
8
Pleomorphic carcinoma of the lung: a surgical outcome.
J Thorac Cardiovasc Surg. 2007 Aug;134(2):399-404. doi: 10.1016/j.jtcvs.2007.04.018.
9
Palliative chemotherapy for pulmonary pleomorphic carcinoma.
Lung Cancer. 2007 Oct;58(1):112-5. doi: 10.1016/j.lungcan.2007.05.006. Epub 2007 Jun 18.
10
Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases.
Am J Surg Pathol. 2003 Mar;27(3):311-24. doi: 10.1097/00000478-200303000-00004.
Zotero 插件